BackOlink Holding AB (publ) Overview

Olink Holding AB (publ) EBIT

Olink Holding AB (publ)'s EBIT is $-53M, below the Healthcare sector average of $110B.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$26.23M
↓ 51.43% YoY

As of Mar 31, 2024

Annual EBIT (TTM)

-$53.47M
↓ 55.51% YoY

Trailing 12 months ending Mar 31, 2024

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Olink Holding AB (publ) (OLK) FAQ

Olink Holding AB (publ) posts a EBIT of $-53M as of March 2024. That compares with $-34M in the prior-year period — down 55.5% year over year. That is below the Healthcare sector average of $110B. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Olink Holding AB (publ)'s EBIT was $-34M. The latest reading is $-53M — a 55.5% year-over-year decrease (period ending March 2024). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a EBIT near $110B is typical. Olink Holding AB (publ)'s $-53M is lower that level. That is roughly 100.0% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

EBIT is one piece of Olink Holding AB (publ)'s financial statement story. At $-53M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for OLK's EBIT usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $110B), and (3) consistency with growth and profitability. This page covers the first two; Olink Holding AB (publ)'s other metric pages and overview cover the third.